학술논문
A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune).
Document Type
Article
Author
McKay, Rana R.; Liu, Lin; Pu, Minya; Araneta, Arlene; Wang, Luke; Castano, Neremiah; Gomez, Jennifer; Ajmera, Archana; Ye, Huihui; Pili, Roberto; Runcie, Karie; McHugh, Deaglan Joseph; Offit, Kenneth; Paller, Channing Judith; Haas, Naomi B.; Javier-Desloges, Juan; Kane, Christopher J.; Seibert, Tyler M; Bagrodia, Aditya
Source
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS353-TPS353, 97p
Subject
Language
ISSN
0732183X